GGrantIndex
← Leaderboards

Stanley M Spinola

Indiana University Indianapolis

$14,547,790
Attributed
$14,547,790
Total exposure
31
Grants
18
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.3M · FY200524
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$28,114,936 · 32

By mechanism

U19$14,877,869 · 5
R01$10,670,021 · 4
T32$2,402,355 · 1
M01$134,689 · 20
R13$30,002 · 2

Top collaborators

No co-investigators on record.

Most similar at Indiana University Indianapolis

Same institution · by research overlap

Others in their field

Top investigators on “Sexually Transmitted Diseases

Research focus

Sexually Transmitted DiseasesHemophilus DucreyiUlcerInfectionTransmission ProcessPathogenOrganismClinical ResearchImmune ResponseIn VivoGenital SystemLesionMutantBiologyMacrophagePathogenesisSkinVirulenceResponseHuman SubjectIn VitroResearch PersonnelHiv-1Abscess

Grant awards (128)

Determination of the Interactome between Haemophilus ducreyi and the Human Host.$580,405
R01 · FY2024 · AI · contact PI
Determination of the Interactome between Haemophilus ducreyi and the Human Host.$580,405
R01 · FY2023 · AI · contact PI
Determination of the Interactome between Haemophilus ducreyi and the Human Host.$622,518
R01 · FY2022 · AI · contact PI
Determination of the Interactome between Haemophilus ducreyi and the Human Host.$718,795
R01 · FY2021 · AI · contact PI
Determination of the Interactome between Haemophilus ducreyi and the Human Host.$652,388
R01 · FY2020 · AI · contact PI
The Role of the Skin Microbiome in Cutaneous Ulcers in Children in the Tropics$534,977
R01 · FY2020 · AI · contact PI
The Role of the Skin Microbiome in Cutaneous Ulcers in Children in the Tropics$618,675
R01 · FY2019 · AI · contact PI
The Role of the Skin Microbiome in Cutaneous Ulcers in Children in the Tropics$704,776
R01 · FY2018 · AI · contact PI
Training in Sexually Transmitted Diseases including HIV$205,426
T32 · FY2015 · AI · contact PI
Training in Sexually Transmitted Diseases including HIV$176,612
T32 · FY2014 · AI · contact PI
Pathogenesis of Haemophilus Ducreyi Infections$615,790
R01 · FY2013 · AI · contact PI
Training in Sexually Transmitted Diseases including HIV$204,943
T32 · FY2013 · AI · contact PI
Pathogenesis of Haemophilus Ducreyi Infections$662,829
R01 · FY2012 · AI · contact PI
Training in Sexually Transmitted Diseases including HIV$205,823
T32 · FY2012 · AI · contact PI
Pathogenesis of Haemophilus Ducreyi Infections$113,447
R01 · FY2012 · AI · contact PI
Pathogenesis of Haemophilus Ducreyi Infections$50,726
R01 · FY2012 · AI · contact PI
Pathogenesis of Haemophilus Ducreyi Infections$375,239
R01 · FY2011 · AI · contact PI
Human Immune Response to Haemophilus Ducreyi Infection$355,548
R01 · FY2011 · AI · contact PI
Training in Sexually Transmitted Diseases including HIV$171,113
T32 · FY2011 · AI · contact PI
Biennial Symposium of H. ducreyi Pathogenesis and Chancroid$8,000
R13 · FY2011 · AI · contact PI
Pathogenesis of Haemophilus Ducreyi Infections$395,819
R01 · FY2010 · AI · contact PI
Human Immune Response to Haemophilus Ducreyi Infection$359,357
R01 · FY2010 · AI · contact PI
Training in Sexually Transmitted Diseases Including HIV$173,143
T32 · FY2010 · AI · contact PI
Midwest Sexually Transmitted Infections Topical Microbicide Cooperative Research$666,728
U19 · FY2009 · AI · contact PI
Human Immune Response to Haemophilus Ducreyi Infection$363,200
R01 · FY2009 · AI · contact PI
Chancroid Human Challenge Unit (CHCU)$182,777
U19 · FY2009 · AI · contact PI
Training in Sexually Transmitted Diseases Including HIV$137,282
T32 · FY2009 · AI · contact PI
Administrative Core$70,760
U19 · FY2009 · AI · contact PI
Biennial Symposium on H.ducreyi Pathogenesis and Chancroid$6,000
R13 · FY2009 · AI · contact PI
Midwest Sexually Transmitted Infections Topical Microbicide Cooperative Research$1,450,816
U19 · FY2008 · AI · contact PI
Human Immune Response to Haemophilus Ducreyi Infection$369,805
R01 · FY2008 · AI · contact PI
Training in Sexually Transmitted Diseases Including HIV$178,669
T32 · FY2008 · AI · contact PI
Chancroid Human Challenge Unit$164,563
U19 · FY2008 · AI · contact PI
EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS DUCREYI$233
M01 · FY2008 · RR · contact PI
EVALUATION OF AN WECA MUTANT IN EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS$102
M01 · FY2008 · RR · contact PI
Biennial Symposium on H.ducreyi Pathogenesis & Chancroid$1
R13 · FY2008 · AI · contact PI
Midwest Sexually Transmitted Infections Topical Microbicide Cooperative Research$1,515,945
U19 · FY2007 · AI · contact PI
Human Immune Response to Haemophilus Ducreyi Infection$387,358
R01 · FY2007 · AI · contact PI
Training in Sexually Transmitted Diseases Including HIV$186,459
T32 · FY2007 · AI · contact PI
Chancroid Human Challenge Unit$171,949
U19 · FY2007 · AI · contact PI
Biennial Symposium on H.ducreyi Pathogenesis & Chancroid$6,000
R13 · FY2007 · AI · contact PI
EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS DUCREYI$2,737
M01 · FY2007 · RR · contact PI
EVALUATION OF AN WECA MUTANT IN EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS$1,198
M01 · FY2007 · RR · contact PI
Midwest STIs Topical Microbicide Cooperative Research$1,486,128
U19 · FY2006 · AI · contact PI
Training in Sexually Transmitted Diseases Including HIV$177,419
T32 · FY2006 · AI · contact PI
Chancroid Human Challenge Unit$153,971
U19 · FY2006 · AI · contact PI
EVALUATION OF AN DLTA MUTANT IN EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS$11,110
M01 · FY2006 · RR · contact PI
EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS DECREYI$9,292
M01 · FY2006 · RR · contact PI
EVALUATION OF AN OMPP2A OMPP2B DOUBLE MUTANT IN EXPERIMENTAL HUMAN INFECTION$4,848
M01 · FY2006 · RR · contact PI
EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS DUCREYI IN PERSONS WHO ARE HIV$2,923
M01 · FY2006 · RR · contact PI
Biennial Synposium on H.ducreyi Pathogenesis & Chancroid$1
R13 · FY2006 · AI · contact PI
Midwest STIs Topical Microbicide Cooperative Research$1,381,240
U19 · FY2005 · AI
Pathogenesis of Haemophilus ducreyi Infections$335,250
R01 · FY2005 · AI
Chancroid Human Challenge Unit$148,833
U19 · FY2005 · AI
Training in Sexually Transmitted Diseases Including HIV$111,862
T32 · FY2005 · AI
EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS DUCREYI IN PERSONS WHO ARE HIV$38,924
M01 · FY2005 · RR
EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS DECREYI$19,218
M01 · FY2005 · RR
Biennial Symposium on H.ducreyi Pathogenesis &Chancroid$10,000
R13 · FY2005 · AI
EVALUATION OF AN OMPP2A OMPP2B DOUBLE MUTANT IN EXPERIMENTAL HUMAN INFECTION$7,510
M01 · FY2005 · RR
EVALUATION OF A NCAA MUTANT IN EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS$7,290
M01 · FY2005 · RR
Midwest STIs Topical Microbicide Cooperative Research$1,355,808
U19 · FY2004 · AI
Pathogenesis of Haemophilus ducreyi Infections$335,250
R01 · FY2004 · AI
Chancroid Human Challenge Unit$143,028
U19 · FY2004 · AI
Training in Sexually Transmitted Diseases Including HIV$123,975
T32 · FY2004 · AI
Experimental Human Infection with Haemophilus ducreyi$12,958
M01 · FY2004 · RR
EVALUATION OF A TADA MUTANT IN EXPERIMENTAL HUMAN INFECTION WITH H. DUCREYI$10,715
M01 · FY2004 · RR
EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS DUCREYI IN PERSONS WHO ARE HIV$3,887
M01 · FY2004 · RR
Evaluation of LspA1 &LspA2 double mutant in exp. human infection w/H.ducreyi$1,744
M01 · FY2004 · RR
MIDWEST SEXUALLY TRANSMITTED DISEASES COOPERATIVE RESEAR$1,466,231
U19 · FY2003 · AI
Pathogenesis of Haemophilus ducreyi Infections$313,200
R01 · FY2003 · AI
Training in Sexually Transmitted Diseases Including HIV$122,383
T32 · FY2003 · AI
MIDWEST SEXUALLY TRANSMITTED DISEASES COOPERATIVE RESEAR$30,219
U19 · FY2003 · AI
MIDWEST SEXUALLY TRANSMITTED DISEASES COOPERATIVE RESEAR$1,413,852
U19 · FY2002 · AI
Pathogenesis of Haemophilus ducreyi Infections$313,690
R01 · FY2002 · AI
Training in Sexually Transmitted Diseases Including HIV$118,387
T32 · FY2002 · AI
PAL MUTANT IN EXPERIMENTAL HAEMOPHILUS DUCREYI INFECTION$0
M01 · FY2002 · RR
HUMAN IMMUNE RESPONSE TO HAEMOPHILUS DUCREYI INFECTION$0
U19 · FY2002 · AI
CDT &HEMOLYSIN MUTANT IN HAEMOPHILUS DUCREYI INFECTION$0
M01 · FY2002 · RR
CYTOLETHAL DISTENDING TOXIN MUTANT IN HAEMOPHILUS INFECT$0
M01 · FY2002 · RR
SIALYLTRANSFERASE MUTANT IN EXPERIMENT HAEMOPHILUS INFEC$0
M01 · FY2002 · RR
MAJOR OUTER MEMBRANE PROTEIN IN HAEMOPHILUS DUCREYI$0
M01 · FY2002 · RR
EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS DUCREYI$0
M01 · FY2002 · RR
MIDWEST SEXUALLY TRANSMITTED DISEASES COOPERATIVE RESEAR$1,447,929
U19 · FY2001 · AI
Pathogenesis of Haemophilus ducreyi Infections$310,574
R01 · FY2001 · AI
Training in Sexually Transmitted Diseases Including HIV$108,859
T32 · FY2001 · AI
Midwest STD Cooperative Research Center$65,058
U19 · FY2001 · AI
PAL MUTANT IN EXPERIMENTAL HAEMOPHILUS DUCREYI INFECTION$0
M01 · FY2001 · RR
MAJOR OUTER MEMBRANE PROTEIN IN HAEMOPHILUS DUCREYI$0
M01 · FY2001 · RR
HUMAN IMMUNE RESPONSE TO HAEMOPHILUS DUCREYI INFECTION$0
U19 · FY2001 · AI
HUMAN IMMUNE RESPONSE TO HAEMOPHILUS DUCREYI INFECTION$0
U19 · FY2001 · AI
CDT &HEMOLYSIN MUTANT IN HAEMOPHILUS DUCREYI INFECTION$0
M01 · FY2001 · RR
EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS DUCREYI$0
M01 · FY2001 · RR
CYTOLETHAL DISTENDING TOXIN MUTANT IN HAEMOPHILUS INFECT$0
M01 · FY2001 · RR
SIALYLTRANSFERASE MUTANT IN EXPERIMENT HAEMOPHILUS INFEC$0
M01 · FY2001 · RR
MIDWEST SEXUALLY TRANSMITTED DISEASES COOPERATIVE RESEAR$1,277,362
U19 · FY2000 · AI
HUMAN IMMUNE RESPONSE TO HAEMOPHILUS DUCREYI INFECTION$137,421
U19 · FY2000 · AI
HUMAN IMMUNE RESPONSE TO HAEMOPHILUS DUCREYI INFECTION$137,421
U19 · FY2000 · AI
MIDWEST SEXUALLY TRANSMITTED DISEASES COOPERATIVE RESEAR$9,830
U19 · FY2000 · AI
CDT &HEMOLYSIN MUTANT IN HAEMOPHILUS DUCREYI INFECTION$0
M01 · FY2000 · RR
CDT &HEMOLYSIN MUTANT IN HAEMOPHILUS DUCREYI INFECTION$0
M01 · FY2000 · RR
CDT &HEMOLYSIN MUTANT IN HAEMOPHILUS DUCREYI INFECTION$0
M01 · FY2000 · RR
CDT &HEMOLYSIN MUTANT IN HAEMOPHILUS DUCREYI INFECTION$0
M01 · FY2000 · RR
CDT &HEMOLYSIN MUTANT IN HAEMOPHILUS DUCREYI INFECTION$0
M01 · FY2000 · RR
PAL MUTANT IN EXPERIMENTAL HAEMOPHILUS DUCREYI INFECTION$0
M01 · FY2000 · RR
PAL MUTANT IN EXPERIMENTAL HAEMOPHILUS DUCREYI INFECTION$0
M01 · FY2000 · RR
PAL MUTANT IN EXPERIMENTAL HAEMOPHILUS DUCREYI INFECTION$0
M01 · FY2000 · RR
PAL MUTANT IN EXPERIMENTAL HAEMOPHILUS DUCREYI INFECTION$0
M01 · FY2000 · RR
PAL MUTANT IN EXPERIMENTAL HAEMOPHILUS DUCREYI INFECTION$0
M01 · FY2000 · RR
CYTOLETHAL DISTENDING TOXIN MUTANT IN HAEMOPHILUS INFECT$0
M01 · FY2000 · RR
CYTOLETHAL DISTENDING TOXIN MUTANT IN HAEMOPHILUS INFECT$0
M01 · FY2000 · RR
CYTOLETHAL DISTENDING TOXIN MUTANT IN HAEMOPHILUS INFECT$0
M01 · FY2000 · RR
CYTOLETHAL DISTENDING TOXIN MUTANT IN HAEMOPHILUS INFECT$0
M01 · FY2000 · RR
CYTOLETHAL DISTENDING TOXIN MUTANT IN HAEMOPHILUS INFECT$0
M01 · FY2000 · RR
SIALYLTRANSFERASE MUTANT IN EXPERIMENT HAEMOPHILUS INFEC$0
M01 · FY2000 · RR
SIALYLTRANSFERASE MUTANT IN EXPERIMENT HAEMOPHILUS INFEC$0
M01 · FY2000 · RR
SIALYLTRANSFERASE MUTANT IN EXPERIMENT HAEMOPHILUS INFEC$0
M01 · FY2000 · RR
SIALYLTRANSFERASE MUTANT IN EXPERIMENT HAEMOPHILUS INFEC$0
M01 · FY2000 · RR
SIALYLTRANSFERASE MUTANT IN EXPERIMENT HAEMOPHILUS INFEC$0
M01 · FY2000 · RR
MAJOR OUTER MEMBRANE PROTEIN IN HAEMOPHILUS DUCREYI$0
M01 · FY2000 · RR
MAJOR OUTER MEMBRANE PROTEIN IN HAEMOPHILUS DUCREYI$0
M01 · FY2000 · RR
MAJOR OUTER MEMBRANE PROTEIN IN HAEMOPHILUS DUCREYI$0
M01 · FY2000 · RR
MAJOR OUTER MEMBRANE PROTEIN IN HAEMOPHILUS DUCREYI$0
M01 · FY2000 · RR
MAJOR OUTER MEMBRANE PROTEIN IN HAEMOPHILUS DUCREYI$0
M01 · FY2000 · RR
EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS DUCREYI$0
M01 · FY2000 · RR
EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS DUCREYI$0
M01 · FY2000 · RR
EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS DUCREYI$0
M01 · FY2000 · RR
EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS DUCREYI$0
M01 · FY2000 · RR
EXPERIMENTAL HUMAN INFECTION WITH HAEMOPHILUS DUCREYI$0
M01 · FY2000 · RR